The association between proton pump inhibitors and myocardial infarction: What do food and drug administration data tell us?
Objective: There is limited and conflicting evidence on the association between proton pump inhibitors (PPIs) and myocardial infarction (MI). This study aims to examine the occurrence of MI associated with PPI use from the Food and Drug Administration (FDA) Adverse Event Reporting System database. M...
Saved in:
Main Authors: | Jiun Ming Tan (Author), Richard Parsons (Author), Tin Fei Sim (Author), Ya Ping Lee (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2019-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Similar Items
-
Impact of Concomitant Use of Proton Pump Inhibitors and Clopidogrel on Recurrent Stroke and Myocardial Infarction
by: Yong Kang Lee, et al.
Published: (2023) -
Proton Pump Inhibitor for Gastrointestinal Bleeding in Patients with Myocardial Infarction on Dual-Antiplatelet Therapy: A Nationwide Cohort Study
by: Minyoul Baik, et al.
Published: (2024) -
Infectious agents and acute myocardial infarction
by: Sim Sai Tin, et al.
Published: (2015) -
Proton pump inhibitors in pediatric practice
by: Anna A. Shilova, et al.
Published: (2023) -
Proton Pump Inhibitors and Gastric Cancer
by: Seungkyung Kang, et al.
Published: (2021)